Position in LLY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,595,242
+$359,991 QoQ
Shares Held
1,330
-1.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#2,709
of 4,605 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Truvestments Capital LLC holds $19,966,308 across 13 Drug Manufacturers - General names. LLY ranks #5 (8.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
26,544 | $6,741,379 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
60,684 | $3,496,612 | |
| 3 | MRK |
Merck & Co., Inc.
|
25,027 | $3,215,969 | |
| 4 | ABBV |
AbbVie Inc.
|
9,790 | $2,463,555 | |
| 5 | LLY |
ELI LILLY & Co
This page
|
1,330 | $1,595,242 | |
| 6 | PFE |
Pfizer Inc
|
42,672 | $1,027,541 | |
| 7 | AMGN |
Amgen Inc
|
2,481 | $898,419 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,234 | $282,243 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,595,242 | 1,330 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $1,235,251 | 1,343 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,324,005 | 1,232 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $954,513 | 1,251 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $609,592 | 782 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $726,800 | 880 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $519,556 | 673 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $500,556 | 565 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $375,732 | 415 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $318,963 | 410 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $238,997 | 410 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $220,223 | 410 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $168,832 | 360 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $123,631 | 360 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $133,531 | 365 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $110,909 | 343 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $111,210 | 343 | Shares | Sole | 2022-08-09 | |
| 2021-12-31 | $94,743 | 343 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $79,250 | 343 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $78,725 | 343 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $101,256 | 542 | Shares | Other | 2021-05-18 | |
| 2020-12-31 | $57,911 | 343 | Shares | Sole | 2021-02-17 | |
| 2020-09-30 | $29,455 | 199 | Shares | Other | 2020-11-13 | |
| 2020-06-30 | $58,775 | 358 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $27,605 | 199 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||